Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis.J - Área de Salud Badajoz

Ir al contenido principal

Av. de Huelva, 8. 06005 Badajoz

info@areasaludbadajoz.com

info@areasaludbadajoz.com

Guía telefónica
Área de Salud

Inicio Repositorio Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis.J

2018/05

Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis.J

Autores/as:

Gassó P, Mas S, Bioque M, Cabrera B, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Vieta E, Castro-Fornieles J, Sarró S, Mané A, Sanjuan J, Llerena A, Lafuente A, Saiz-Ruiz J, Bernardo M

Servicio:

Centro de Investigación Clínica de Badajoz (CICAB)

Tipo:

Artículo

Materia:

{«label»:»Resumen PubMed»,»link»:»https://www.ncbi.nlm.nih.gov/pubmed/29767567″}